<DOC>
	<DOCNO>NCT02234752</DOCNO>
	<brief_summary>Aim : To examine efficacy combination galantamine memantine treatment cognitive deficit outpatient schizophrenia . Hypothesis : A combination galantamine memantine improve cognitive impairment patient schizophrenia . This open-label study evaluate whether six week course galantamine ER memantine XR effective improve cognitive performance patient schizophrenia schizoaffective disorder . The primary outcome measure change level cognition measure MATRICS Consensus Cognitive Battery ( MCCB ) . The result MATRICS collaborative project recommend need standardize cognitive test better distinguish different facet cognitive dysfunction schizophrenia . The MCCB ass follow seven domain : attention/vigilance , reason problem solving , process speed , social cognition , verbal learn memory , visual learn memory , work memory . The MCCB administer baseline end study . We report total score domain score MCCB baseline six week .</brief_summary>
	<brief_title>Galantamine Memantine Cognitive Impairments Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Galantamine</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Be male female age 18 55 year ( inclusive ) . Have DSM5 diagnosis schizophrenia schizoaffective disorder confirm medical record . Duration illness must â‰¥ 1year . Be clinically stable least two month ( i.e. , `` moderately severe '' severity rating follow BPRS item : hallucination , unusual thought content conceptual disorganization . Have psychiatric hospitalization two month prior screen . Be take 1st generation antipsychotic prescribe absence concomitant anticholinergic 2nd generation antipsychotic minimal extrapyramidal symptom Have SimpsonAngus Score ( SAS ) &lt; 6 Be current medication regimen least six week screen stable dose frequency least 30 day screen . Be good general health expect complete clinical study design . Subjects childbearing potential must agree use two form nonhormonal contraception ( dual contraception ) consistently screen treatment period trial , 30 day final dose study medication . Females childbearing potential must negative urine pregnancy test baseline . This may also do subsequent visit subject report possibility pregnancy . Have negative urine drug screen screen . This may repeat discretion primary investigator . Have adequate hearing , vision , language skill perform procedure specify protocol . Be capable provide informed consent voluntarily provide informed consent . Have active , clinically significant unstable medical condition 30 day prior screen . Have dementia . Are pregnant , breastfeeding , plan become pregnant Are take think take oral contraceptive injectable contraceptive . Are take benztropine dose great 2 mg daily . Have history Pervasive Development Disorder . Have history significant head injury/trauma ( define one follow : loss consciousness one hour ; recur seizure result head injury ; and/or clear cognitive sequela injury require cognitive rehabilitation . ) Have allergy anticholinesterase medication ( galantamine , rivastigimine , donepezil ) memantine Have DSM5 diagnosis alcohol and/or substance use disorder ( caffeine tobacco ) within last 6 month . Are take restricted medication : Amitriptyline , Doxepin , Imipramine , Flexeril , Clozapine , and/or cortisol ( oral , injectable , topical steroid medication ) Have history seizure exclude childhood febrile seizure Have receive ECT within last three month prior screen . Have participate clinical trial psychotropic medication within last two month prior screen . Have `` severe '' `` extremely severe '' severity rating BPRS item : hallucination unusual thought content . Have `` moderate '' severity rating BPRS item conceptual disorganization . Are currently take 3 antipsychotic medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Cognition</keyword>
	<keyword>Cognitive Impairment</keyword>
	<keyword>Galantamine</keyword>
	<keyword>Memantine</keyword>
</DOC>